The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies - Université de Rennes Accéder directement au contenu
Article Dans Une Revue HemaSphere Année : 2021

The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies

Hermann Einsele
Natacha Bolaños
  • Fonction : Auteur

Résumé

In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research(1) aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1-2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European Hematology Research. the 11 EHA Research Roadmap sections include normal hematopoiesis; malignant lymphoid diseases; malignant myeloid diseases; anemias and related diseases; platelet disorders; blood coagulation and hemostatic disorders; transfusion medicine; infections in hematology; hematopoietic stem cell transplantation; CAR-T and Other cell-based immune therapies; and gene therapy.
Fichier principal
Vignette du fichier
Einsele.pdf (375.36 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03367656 , version 1 (02-06-2022)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

Citer

Hermann Einsele, Javier Briones, Fabio Ciceri, Irene García Cadenas, Fred Falkenburg, et al.. The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies. HemaSphere, 2021, 5 (10), pp.e642. ⟨10.1097/HS9.0000000000000642⟩. ⟨hal-03367656⟩
19 Consultations
20 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More